Craft Health’s tailored drug technology just received a boost. The Singapore 3D printed pharmaceuticals manufacturer announced it has raised S$1.42 million ($1.03 million) in its latest Pre-Series A. The funds will propel Craft Health’s 3D printing platform as it prepares for South-East Asia’s first clinical trial on 3D printed pharmaceuticals. Also in the works are various 3D printed nutrition and supplementation initiatives with several nutraceutical companies.
Led by Tokyo-based venture capital (VC) firm Mistletoe, the round also had participation from Kyoto medical equipment manufacturer Arkray’s corporate venture arm Arkray 4U; neuroradiologist and founder of 3DHeals, Jenny Chen; and angel investor Chang-Hung Tseng. This new cash infusion brings the total raised by Craft Health to date to S$2.4 million ($1.7 million)…
